Trial Profile
A retropective study investigating efficacy and safety of abatacept in patients with rheumatoid arthritis in routine clinical practice and the prognostic factors affecting clinical outcomes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ALTAIR
- 24 Oct 2016 New trial record
- 31 Aug 2016 Results published in the Clinical and Experimental Rheumatology